Location History:
- Kolkatta, IN (2007)
- Kolkata, IN (2002 - 2009)
- Calcutta, IN (2003 - 2011)
- West Bengal, IN (2014)
Company Filing History:
Years Active: 2002-2014
Title: **Bikash Chandra Pal: Pioneering Innovations in Pharmaceutical Research**
Introduction
Bikash Chandra Pal, a prominent inventor based in Calcutta, India, has made significant contributions to the field of pharmaceutical research. With an impressive portfolio that includes 14 patents, his work not only demonstrates innovation but also aims to address critical health challenges.
Latest Patents
Pal's latest patents showcase his dedication to developing novel treatments. One of his notable inventions is a pharmaceutical composition known as Acaciaside-B (Ac-B), which has shown promise as a preventive measure against HIV infection. This compound is characterized by its virucidal and spermicidal activities, making it a potential candidate for use in vaginal contraceptive formulations. With its anti-HIV properties surfacing at a tolerably low concentration, Ac-B also boasts a non-mutagenic nature that does not disrupt the ecological niche, positioning it as a superior ingredient for chemical barriers against HIV-1 infection.
Another significant development is his herbal composition designed to treat CD33+ acute and chronic myeloid leukemia. The method involves utilizing specific fractions obtained from a water:methanol extract via column chromatography, with a precise ratio of water and methanol ranging from 1:5 to 5:1. These fractions, characterized by their unique retention times, can be employed individually or in combination for effective treatment in both animals and humans.
Career Highlights
Bikash Chandra Pal currently works at the Council of Scientific & Industrial Research, where he plays an integral role in advancing pharmaceutical research and development. His pioneering inventions contribute not only to scientific literature but also to practical applications that can positively impact public health.
Collaborations
Throughout his career, Pal has collaborated with esteemed colleagues, including Santu Bandyopadhyay and Samir Bhattacharya. Together, they work on innovative projects aimed at addressing pressing medical concerns, further enhancing the reputation of their research institution.
Conclusion
Bikash Chandra Pal exemplifies the spirit of innovation in pharmaceutical sciences. His groundbreaking patents in the areas of HIV prevention and leukemia treatment highlight his commitment to developing effective healthcare solutions. As he continues to collaborate with other experts in the field, Pal's contributions will undoubtedly pave the way for future advancements in medicine.